Tag

capacity

Panel Discussion: Reflecting on the Past, Envisioning the Future: Shaping the New Landscape of Biomanufacturing
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Panel Discussion: Reflecting on the Past, Envisioning the Future: Shaping the New Landscape of Biomanufacturing

Assessing Changes in the CMC Ecosystem: Are We Overbuilding Capacity Again?
Uniting for Success: Strategies to Prevent Fragmentation and Foster Collaboration in Biomanufacturing
Pioneering New Ventures: Reasons to Establish a New Company Today and Anticipating Future Growth in the Business Ecosystem
Evaluating Production Platforms for Emerging Modalities: Which Platforms Will Best Serve the Future of Medicine?
Navigating the Future of Existing Platforms: Efficiently Addressing Market Needs for Established Therapies such as mAbs, ADCs, and mRNA-based Treatments

Continue reading
Welcome Day Panel: The Evolution of Innovative Modalities —Defining the Future of Manufacturing & Development
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Welcome Day Panel: The Evolution of Innovative Modalities —Defining the Future of Manufacturing & Development

Science outpacing Industrialization of Technology: Reviewing next generation cell and gene therapy platforms/technologies, gene editing technologies to unlock new possibilities.
Manufacturing to Scale: Scaling up to meet demand, comparability challenges, production capacity, AI tools and AAV production will drive speed to market/approval
Regulatory Evolution: evolving regulatory frameworks and innovative products necessitate industry and local and global regulatory collaboration to define efficient pathways to approval
Economic/Global Expansion: expanding access to ATMP’s in new regions, reducing cost of goods via production efficiency, expanding global infrastructure to facilitate access to new patients

Continue reading
Advancing Cell Therapy Industrialization: Key Focus Areas
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Advancing Cell Therapy Industrialization: Key Focus Areas

Thomas has been serving as the Senior Vice President of Cell Therapy Development and Operations at BMS since August 2023. Before joining BMS, he held multiple roles with Merck & Co, where he gained experience in basic research, early and late-stage process development, capital project management, site-based technical operations, commercialization, manufacturing science and technology, and supply chain. Before that, Thomas worked for startup, GlycoFi, founded at Dartmouth College, where he conducted post-doctoral research after receiving his PhD in Bioprocess Engineering from the University of Cape Town in South Africa.

Continue reading
The Coming Patient Treatment Crisis
LIFE SCIENCES, VIDEO, LIFE SCIENCES

The Coming Patient Treatment Crisis

Fabian Gerlinghaus is Co-Founder and Chief Executive Officer of Cellares. He is driven by a strong sense of purpose and is passionate about meeting total patient demand for cell therapies globally. With 10+ years of experience as an innovator and a leader, Fabian has established a track record of assembling top-performing teams to successfully drive novel bioprocessing technologies from ideation to commercial readiness. Prior to co-founding Cellares, Fabian served as Chief Innovation Officer at Synthego, where he co-invented the company’s proprietary RNA synthesizer technology and helped grow the company from five to more than 230 employees. He successfully led the interdisciplinary team that took synthesizer technology from whiteboard sketch to production-ready instruments within two years, enabling the company to be the first to market with its CRISPR/Cas9 product portfolio. He earned a master’s degree in aerospace engineering from the Technical University of Munich, and an honors degree in technology management from the Center for Digital Technology and Management, Munich.

Continue reading
Panel: Digital Change for Future-Proof Biomanufacturing: How Biopharmas and CDMOs Redefine Operations
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Panel: Digital Change for Future-Proof Biomanufacturing: How Biopharmas and CDMOs Redefine Operations

Data Ecosystem for the Future: We’ll look at how AI and data-centric architectures are setting the stage for future innovations and predictive capabilities
Scale Out and Up Across Manufacturing Networks: We’ll discuss strategies for standardizing and integrating digital processes across multi-site and decentralized networks
Accelerate Technology Transfers and New Product Introductions: We’ll examine how digital solutions are transforming tech transfer and expediting the launch of new products, including how global contract development manufacturing organizations (CDMOs), are accelerating knowledge transfer and reducing time-to-market by up to 40%
Enable Composable Architectures: We will discuss how composable architecture addresses the limitations of monolithic systems, ensuring flexibility, scalability, and better data-driven decision-making

Continue reading
Using Innovation to Accelerate and Optimize Your Drug Manufacturing Scale-Up Strategy
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Using Innovation to Accelerate and Optimize Your Drug Manufacturing Scale-Up Strategy

Joe Goodman is the Global Vice President of Customer Transformation at Honeywell Life Sciences where he leads efforts to strategically partner with global clients and prospects to achieve their business goals. Joe is recognized as a thought leader in the fields of life sciences quality and manufacturing. Prior to joining Sparta Systems which subsequently became Honeywell Life Sciences through acquisition, Joe spent more than 7 years at Merrill Lynch as a Six Sigma Black Belt. He owes much of his penchant for process and solution design to his time spent in that role. Joe also speaks internationally at Compliance and Manufacturing events.

Continue reading
‘First in Human’ Continuous Manufacturing in Biopharmaceuticals — A Conversation with Magnus Schroeder of Just – Evotec Biologics
LIFE SCIENCES, VIDEO, LIFE SCIENCES, PODCAST

‘First in Human’ Continuous Manufacturing in Biopharmaceuticals — A Conversation with Magnus Schroeder of Just – Evotec Biologics

At the 2024 edition of the Biomanufacturing World Summit series we sat down with Magnus Schroeder, the VP, Process & Product Design for Just – Evotec Biologics, to talk about some of the advantages of continuous manufacturing in biopharmaceutical manufacturing, especially for companies whose products are approaching the First in Human (FIH) stage. It is never too early to think about process optimization, scalability, and controlling costs, but there is an understandable position where companies focused on the medicine and the science believe that can be sorted out later. Just – Evotec Biologics is a passionate advocate for taking lessons from other industries that build their businesses’ success into the R&D stage of their products’ development. So what does that look like in the Life Sciences? What role do CDMOs need to play to help the industry succeed at this, especially at the crucial FIH stage? For all this and more, give this episode a listen!

Continue reading
How CDMOs are Contributing to the Ongoing Future of Medicine — A Conversation with Nick Maragos of Northway Biotech
LIFE SCIENCES, VIDEO, LIFE SCIENCES, PODCAST

How CDMOs are Contributing to the Ongoing Future of Medicine — A Conversation with Nick Maragos of Northway Biotech

At the 2024 edition of the Biomanufacturing World Summit series we sat down with Nick Maragos of Northway Biotech to talk about how biopharmaceutical manufacturers are increasingly partnering with CDMOs to advance the future of medicine, how that working relationship is evolving over time, and what CDMOs need to do to continue to grow and meet the needs of the industry. With special reference to Northway Biotech’s own example, Nick talks about how companies can ensure they are compatible, what the working relationship needs to be, and what factors need to be included in any informed decision-making before and during a partnership. Give this episode a listen!

Continue reading
Contract Manufacturing as an Enterprise Capability Multiplier When Strategically Managed
FOOD MANUFACTURING, VIDEO, MANUFACTURING

Contract Manufacturing as an Enterprise Capability Multiplier When Strategically Managed

Tanya Peterson is an accomplished executive with a proven track record in driving operational excellence and fostering strategic partnerships in the consumer goods industry. As the Vice President of External Manufacturing at Mondelez International, she plays a pivotal role in overseeing the company’s external manufacturing operations in North America. With over two decades of experience in supply chain management, Tanya has honed her expertise in optimizing manufacturing processes, ensuring product quality, and maximizing efficiency across diverse production networks. Her commitment to innovation and continuous improvement has led to significant cost savings and enhanced productivity within Mondelez’s external manufacturing ecosystem. Tanya is recognized for her strong leadership skills and ability to build collaborative relationships with external partners, suppliers, and internal stakeholders. Under her guidance, Mondelez has strengthened its global manufacturing capabilities, enabling the company to meet evolving consumer demands while maintaining the highest standards of quality and safety. Prior to joining Mondelez, Tanya held various leadership positions in supply chain management at Danone & Georgia Pacific, where she spearheaded initiatives to streamline operations and drive business growth. She holds a Bachelor’s degree in Mechanical Engineering & a Master’s Degree in Chemical Engineering from Canadian universities, along with an MBA from Portland State University. She continues to stay abreast of emerging trends and best practices in manufacturing and supply chain management. As Vice President of External Manufacturing at Mondelez, Tanya Peterson continues to leverage her expertise and vision to drive sustainable growth and innovation, further solidifying Mondelez’s position as a global leader in the consumer goods sector.

Continue reading
A Speaker Roundtable from NASCES24 — A Supply Chain Conversation with SAP, General Mills, Google, and Walmart
SUPPLY CHAIN — NA, VIDEO, SUPPLY CHAIN, PODCAST

A Speaker Roundtable from NASCES24 — A Supply Chain Conversation with SAP, General Mills, Google, and Walmart

For this special episode of Executive Platforms’ BluEPrint Podcast series we had some of the top speakers from the 2024 edition of the long-running and successful North American Supply Chain Executive Summit series sit down and speak to the challenges and opportunities submitted by attendees of the event as they filled out their delegate profiles, weighted by popularity.

With topics ranging from controlling costs, procurement and sourcing, digital transformation and AI, forecasting and S&OP, to managing growth and capacity in a changing business landscape while working to be an employer of choice in the battle for Top Talent, and much more, this wide-ranging conversation will see four senior executives from four very different companies speaking to the issues, ideas, innovations, and inspirations that matter to all of them as prompted by their peers. It is a fantastic deep dive into what is most relevant to supply chain organizations today. Give it a listen!

Continue reading
The CDMO of the Future
LIFE SCIENCES, VIDEO, LIFE SCIENCES

The CDMO of the Future

JR Humbert is currently the VP, Quality at INCOG BioPharma Services, and created and implemented the quality system at INCOG, which in three years went from company creation through successful FDA inspection in 3 years.

JR has over 20 years of pharmaceutical and biotechnology industry experience in validation, quality, technology transfer, process engineering, and program management. Some of JR’s previous companies include Piramal Pharma Solutions, Roche/Genentech, Hospira, and Cook Pharmica.

JR has participated in multiple global health authority inspections and developed inspection responses. JR has an MBA from Indiana University, and a BA in Chemistry and Biochemistry from the University of Colorado-Boulder.

Continue reading
The Role CDMOs Play in the Future of Medicine — A Conversation with JR Humbert of INCOG BioPharma Services
LIFE SCIENCES, VIDEO, LIFE SCIENCES, PODCAST

The Role CDMOs Play in the Future of Medicine — A Conversation with JR Humbert of INCOG BioPharma Services

JR Humbert is currently the VP, Quality at INCOG BioPharma Services, and created and implemented the quality system at INCOG, which in three years went from company creation through successful FDA inspection in 3 years.

JR has over 20 years of pharmaceutical and biotechnology industry experience in validation, quality, technology transfer, process engineering, and program management. Some of JR’s previous companies include Piramal Pharma Solutions, Roche/Genentech, Hospira, and Cook Pharmica.

JR has participated in multiple global health authority inspections and developed inspection responses. JR has an MBA from Indiana University, and a BA in Chemistry and Biochemistry from the University of Colorado-Boulder.

Continue reading
Building Responsiveness for Growth
MANUFACTURING, VIDEO, MANUFACTURING

Building Responsiveness for Growth

Anup Dutt is the VP Technical Director Consumer & Professional Product Divisions at L’Oreal. Anup is an accomplished Industrial Operations Director with extensive experience in leading development and launch of greenfield manufacturing sites, managing consolidation, and transforming existing operations. He has a proven track record of driving business continuity in response to major external and internal events.

Continue reading